Hanson Pharmaceuticals (002412.SZ) announced semi-annual results, with net profit of 107 million yuan to mother, an increase of 55.52% over the previous year

According to Zhitong Finance App, Hanson Pharmaceuticals (002412.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 476 million yuan; net profit attributable to shareholders of listed companies was 107 million yuan, an increase of 55.52% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 101 million yuan, an increase of 56.26% year on year; basic earnings per share were 0.2118 yuan.